OTHER DISEASESOP 09
DIRECT ORAL ANTICOAGULANTS IN SICKLE CELL DISEASE, WHERE WE STAND AND WHERE WE ARE HEADING: A SYSTEMATIC REVIEW
Waail Rozi, Elrazi Ali, Alaa Rahhal, Abdulrahman Al-Mashdali, Yousef Hailan, Mohamed Yassin
Hamad Medical Corporation
Lido
2326
Vezesque se leu este artigo
951
Total PDF
1375
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 7 | 33 | 24 | 57 |
| 2025 6 | 38 | 22 | 60 |
| 2025 5 | 38 | 15 | 53 |
| 2025 4 | 42 | 13 | 55 |
| 2025 3 | 48 | 16 | 64 |
| 2025 2 | 41 | 17 | 58 |
| 2025 1 | 29 | 14 | 43 |
| 2024 12 | 32 | 14 | 46 |
| 2024 11 | 46 | 24 | 70 |
| 2024 10 | 44 | 28 | 72 |
| 2024 9 | 50 | 21 | 71 |
| 2024 8 | 52 | 40 | 92 |
| 2024 7 | 29 | 20 | 49 |
| 2024 6 | 39 | 22 | 61 |
| 2024 5 | 39 | 27 | 66 |
| 2024 4 | 30 | 25 | 55 |
| 2024 3 | 34 | 24 | 58 |
| 2024 2 | 32 | 25 | 57 |
| 2024 1 | 35 | 20 | 55 |
| 2023 12 | 25 | 22 | 47 |
| 2023 11 | 50 | 29 | 79 |
| 2023 10 | 25 | 37 | 62 |
| 2023 9 | 33 | 37 | 70 |
| 2023 8 | 30 | 13 | 43 |
| 2023 7 | 29 | 11 | 40 |
| 2023 6 | 35 | 16 | 51 |
| 2023 5 | 33 | 17 | 50 |
| 2023 4 | 20 | 9 | 29 |
| 2023 3 | 25 | 21 | 46 |
| 2023 2 | 20 | 21 | 41 |
| 2023 1 | 16 | 11 | 27 |
| 2022 12 | 33 | 18 | 51 |
| 2022 11 | 24 | 15 | 39 |
| 2022 10 | 28 | 19 | 47 |
| 2022 9 | 29 | 27 | 56 |
| 2022 8 | 27 | 27 | 54 |
| 2022 7 | 23 | 23 | 46 |
| 2022 6 | 20 | 26 | 46 |
| 2022 5 | 11 | 19 | 30 |
| 2022 4 | 17 | 22 | 39 |
| 2022 3 | 24 | 23 | 47 |
| 2022 2 | 18 | 22 | 40 |
| 2021 1 | 18 | 18 | 36 |
| 2021 12 | 21 | 19 | 40 |
| 2021 11 | 10 | 18 | 28 |
Mostrar tudo
